9 Screening for fetal and genetic abnormalities

American College of Obstetricians and Gynecologists, 1987 Andrews, 1986 Carson, 1990, Spontaneous Abortion, 559 Crow, 1973, Population perspective The Cystic Fibrosis Genetic Analysis Consortium, 1990, Worldwide survey of ΔF508 mutation—report from The Cystic Fibrosis Genetic Analysis Consortium, American Journal of Human Genetics, 47, 354 DiMaio, 1987, Screening for fetal Down's syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels, New England Journal of Medicine, 317, 342, 10.1056/NEJM198708063170603 Elias, 1991, Carrier screening for cystic fibrosis: implications for obstetric and gynecologic practice, American Journal of Obstetrics and Gynecology, 164, 1077, 10.1016/0002-9378(91)90589-J 1986 Harrison, 1991 Hook, 1981, Rates of chromosome abnormalities at different maternal ages, Obstetrics and Gynecology, 58, 282 Hook, 1983, Chromosome abnormalities and spontaneous fetal death following amniocentesis: Further data and association with maternal age, American Journal of Human Genetics, 35, 110 Hook, 1983, Chromosomal abnormality rates at amniocentesis and in liveborn infants, Journal of the American Medical Association, 249, 2034, 10.1001/jama.1983.03330390038028 Hook, 1988, Rates of 47,+21 and other cytogenetic abnormalities diagnosed in 1st trimester chorionic villus samples (CVS): Comparison with rates from 2nd trimester amniocentesis, American Journal of Human Genetics, 42, 797 Kerem, 1989, Identification of the cystic fibrosis gene: genetic analysis, Science, 245, 1073, 10.1126/science.2570460 Kuleshov, 1976, Chromosomal anomalies in infants dying during the perinatal period and premature newborn, Human Genetics, 31, 151, 10.1007/BF00296143 Lemna, 1990, Mutation analysis for heterozygote detection and the parental diagnosis of cystic fibrosis, New England Journal of Medicine, 322, 291, 10.1056/NEJM199002013220503 Milunsky, 1986, The prenatal diagnosis of neural tube and other congenital defects, 453 Motulsky, 1975, Public health and long-term genetic implications of intrauterine diagnosis and selective abortion, Birth Defects: Original Article Service, 7, 22 Nadler, 1979, Maternal serum α-fetoprotein screening: Promise not yet fulfilled, Obstetrics and Gynecology, 54, 333 Nadler, 1979, Maternal serum α-fetoprotein screening: Promise not yet fulfilled, American Journal of Obstetrics and Gynecology, 135, 1, 10.1016/S0002-9378(79)80007-1 National Academy of Sciences, Genetic Screening, 1975 National Institutes of Health, 1990, Workshop on Population Screening for the Cystic Fibrosis Gene, New England Journal of Medicine, 323, 70, 10.1056/NEJM199007053230130 Riordan, 1989, Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science, 245, 1066, 10.1126/science.2475911 Rommens, 1989, Identification of cystic fibrosis gene: chromosome walking and jumping, Science, 245, 1059, 10.1126/science.2772657 Simpson, 1991, Genetic counseling and prenatal diagnosis Simpson, 1987, Chromosomal abnormalities in spontaneous abortions: Frequency, pathology and genetic counselling, 51 Simpson, 1989, Prenatal diagnosis of genetic disorders, 78 Simpson, 1987, Maternal serum alpha fetoprotein screening in 1987, Obstetrics and Gynecology, 69, 134 Simpson, 1992 Simpson, 1991, Principles of cytogenetics Simpson, 1981, Genetic counselling and genetic services in obstetrics and gynecology, American Journal of Obstetrics and Gynecology, 140, 70, 10.1016/0002-9378(81)90259-3 Simpson, 1986, Maternal serum alpha-fetoprotein (MSAFP) screening: Low and high values for detection of genetic abnormalities, American Journal of Obstetrics and Gynecology, 155, 593, 10.1016/0002-9378(86)90285-1 Simpson, 1987, Low fetal loss rates after ultrasound proved viability in early pregnancy, Journal of the American Medical Association, 258, 2555, 10.1001/jama.1987.03400180089033 Simpson, 1989, Translocations are infrequent among couples having repeated spontaneous abortions but no other abnormal pregnancies, Fertility and Sterility, 51, 811, 10.1016/S0015-0282(16)60671-4 Simpson, 1991, Does unexplained second trimester (15–20 weeks) MSAFP elevation presage adverse perinatal outcome? Pitfalls and preliminary studies using late second-third trimester MSAFP, American Journal of Obstetrics and Gynecology, 164, 829, 10.1016/0002-9378(91)90525-V Wald, 1977, Maternal serum screening for Down syndrome in early pregnancy, British Medical Journal, 247, 883